 |
PDBsum entry 3utf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Pore analysis for: 3utf calculated with MOLE 2.0
|
PDB id
|
|
|
|
3utf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Pores calculated on whole structure |
 |
Pores calculated excluding ligands
|
|
|
 |
 |
 |
 |
 |
|
 |
|
|
|
 |
 |
|
 |
|
|
|
 |
1 pore,
coloured by radius |
 |
14 pores,
coloured by radius
|
14 pores,
coloured as in list below
|
|
|
 |
 |
 |
Pores are connected internal spaces going through the structure. Only pores longer than 25 Å are shown. |
|
|
 |
|
|
|
 |
Free R
|
 |
|
|
|
|
 |
Length
|
 |
|
|
|
|
 |
HPathy
|
 |
|
|
|
|
 |
HPhob
|
 |
|
|
|
|
 |
Polar
|
 |
|
|
|
|
 |
Rel Mut
|
 |
|
|
|
|
 |
Residue..type
|
 |
|
|
|
|
 |
Ligands
|
 |
|
|
|
|
|
 |
Radius |
 |
1 |
 |
2.13 |
2.13 |
40.3 |
-1.14 |
-0.18 |
13.7 |
79 |
 |
6 |
0 |
6 |
3 |
4 |
1 |
0 |
 |
FDA 511 B
|
 |
 |
2 |
 |
1.84 |
1.94 |
45.7 |
-1.10 |
-0.16 |
10.6 |
75 |
5 |
2 |
5 |
3 |
5 |
2 |
0 |
FDA 511 A
|
 |
3 |
 |
2.09 |
2.15 |
83.2 |
-0.84 |
-0.12 |
12.7 |
79 |
9 |
0 |
9 |
6 |
7 |
2 |
0 |
FDA 511 D SO4 516 D
|
 |
4 |
 |
1.36 |
1.67 |
88.0 |
-1.70 |
-0.34 |
14.2 |
76 |
7 |
5 |
8 |
3 |
8 |
3 |
0 |
FDA 511 D SO4 516 D
|
 |
5 |
 |
1.45 |
2.80 |
88.7 |
-0.26 |
-0.14 |
9.9 |
85 |
3 |
2 |
6 |
15 |
1 |
2 |
0 |
|
 |
6 |
 |
1.83 |
1.90 |
96.3 |
-1.08 |
-0.18 |
14.4 |
80 |
8 |
2 |
8 |
7 |
6 |
3 |
0 |
FDA 511 D SO4 516 D
|
 |
7 |
 |
1.36 |
2.02 |
99.1 |
-0.65 |
-0.08 |
11.0 |
81 |
8 |
1 |
10 |
14 |
6 |
2 |
0 |
FDA 511 C SO4 514 C SO4 517 C
|
 |
8 |
 |
1.44 |
1.70 |
98.7 |
-1.22 |
-0.42 |
12.1 |
85 |
5 |
5 |
10 |
5 |
2 |
3 |
0 |
SO4 516 D
|
 |
9 |
 |
1.41 |
1.65 |
111.3 |
-1.55 |
-0.50 |
14.2 |
85 |
4 |
7 |
9 |
6 |
2 |
4 |
0 |
SO4 516 D
|
 |
10 |
 |
1.42 |
2.82 |
132.6 |
-0.84 |
-0.16 |
12.0 |
80 |
9 |
2 |
13 |
17 |
8 |
4 |
0 |
FDA 511 D SO4 516 D
|
 |
11 |
 |
1.56 |
1.71 |
140.4 |
-1.18 |
-0.26 |
12.9 |
83 |
10 |
3 |
15 |
10 |
7 |
4 |
0 |
FDA 511 C SO4 514 C SO4 517 C
|
 |
12 |
 |
1.42 |
2.86 |
147.6 |
-1.04 |
-0.36 |
11.5 |
84 |
5 |
7 |
13 |
16 |
3 |
5 |
0 |
SO4 516 D
|
 |
13 |
 |
1.43 |
2.85 |
183.2 |
-0.70 |
-0.11 |
11.4 |
82 |
16 |
1 |
19 |
23 |
12 |
4 |
0 |
FDA 511 C SO4 514 C SO4 517 C FDA 511 D SO4 516 D
|
 |
14 |
 |
1.47 |
1.80 |
198.6 |
-0.90 |
-0.26 |
11.1 |
84 |
12 |
6 |
19 |
22 |
7 |
5 |
0 |
FDA 511 C SO4 514 C SO4 517 C SO4 516 D
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Residue-type_colouring |
 |
|
 |
|
Positive
|
Negative
|
Neutral
|
Aliphatic
|
Aromatic
|
Pro & Gly
|
Cysteine
|
|
H,K,R
|
D,E
|
S,T,N,Q
|
A,V,L,I,M
|
F,Y,W
|
P,G
|
C
|
|
|
 |